Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Buy Bristol-Myers Squibb, Merck, 10-Year Treasury ETF And This Payments Stock: CNBC's 'Final Trades'

Published 10/11/2022, 12:57
Updated 10/11/2022, 14:11
© Reuters.  Buy Bristol-Myers Squibb, Merck, 10-Year Treasury ETF And This Payments Stock: CNBC's 'Final Trades'
MRK
-
MRCG
-
BMY
-
MKKGY
-
MRCK34
-

Benzinga - On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Bristol-Myers Squibb Co. (NYSE: NYSE:BMY) as his final trade. Shares of Bristol-Myers Squibb have added almost 30% year to date.

Brian Belski of BMO Capital Markets said that PayPal Holdings Inc . (NASDAQ: NASDAQ:PYPL) is “over performing … levitating after earnings” and is going to move higher if the market turns.

Check out other stocks making moves in the premarket.

Liz Young of BNY Mellon Investment Management said that fear was driving the yield down for the iShares 7-10 Year Treasury Bond (NYSE:IEF) ETF (NASDAQ: IEF) and prices up.

Joseph Terranova of Virtus Investment Partners named Merck & Co Inc. (NYSE: MRK) as his final trade.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.